Regenerative biomaterials and bioimplants processed from human amniotic membrane, with application in the wound care, surgical, sports medicine, ophth....
There’s no risk. Start your trial today to see profiles of MiMedx Group (OTCBB: MDXG; NASDAQ: MDXG) plus 5589 other startups.
Start Free 7 Day Trial Now